文献速递泌尿男性生殖肿瘤

以患者为中心的偏好评估改善局限性前列腺癌患者照护满意度:一项随机对照试验

Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.
PubMed 文献 · J Clin Oncol · 2019-03-12

这项多中心随机对照试验将743例局限性前列腺癌患者随机分为PreProCare干预组(n=372)或常规照护组(n=371),评估照护满意度、决策满意度、决策后悔及治疗选择。干预组24个月时总体满意度较基线改善0.44(SE 0.06;P<.001),相当于0.5个标准差,具临床意义;决策满意且无后悔的比例随时间增加且干预组高于常规照护组(P<.05);低危患者中干预组接受主动监测的比例更高(P<.001)。

要点

  • PreProCare干预组24个月总体满意度较基线改善0.44(SE 0.06;P<.001),相当于0.5个标准差。
  • 24个月时干预组决策满意且无后悔的比例高于常规照护组(P<.05)。
  • 低危患者中干预组接受主动监测的比例高于常规照护组(P<.001)。

核心结论

  • 以患者为中心的PreProCare干预改善了照护满意度、决策满意度,减少了后悔,并使治疗选择与风险分层相匹配。

研究设计与样本

  • 多中心随机对照试验,2014年1月至2015年3月招募743例局限性前列腺癌患者,随机分为PreProCare组(n=372)或常规照护组(n=371)。
  • 在基线及3、6、12、24个月进行评估,采用重复测量分析,并按前列腺癌风险类别比较干预组间的治疗选择。

主要发现

  • 总体满意度分量表24个月较基线的改善在两组间有显著差异(P<.001)。
  • 干预组24个月平均评分较基线改善0.44(SE 0.06;P<.001),相当于0.5个标准差,具临床意义。
  • 报告决策满意且无后悔的比例随时间增加,24个月时干预组高于常规照护组(P<.05)。
  • 低危患者中,干预组接受主动监测的比例高于常规照护组(P<.001)。

局限性

  • 大多数参与者为高收入人群,对普遍性有影响。
  • 需在不同环境中进一步研究PreProCare作为改善临床和患者报告结局机制的有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study the effectiveness of the Patient Preferences for Prostate Cancer Care (PreProCare) intervention in improving the primary outcome of satisfaction with care and secondary outcomes of satisfaction with decision, decision regret, and treatment choice among patients with localized prostate cancer. METHODS: In this multicenter randomized controlled study, we randomly assigned patients with localized prostate cancer to the PreProCare intervention or usual care. Outcomes were satisfaction with care, satisfaction with decision, decision regret, and treatment choice. Assessments were performed at baseline and at 3, 6, 12, and 24 months, and were analyzed using repeated measures. We compared treatment choice across intervention groups by prostate cancer risk categories. RESULTS: Between January 2014 and March 2015, 743 patients with localized prostate cancer were recruited and randomly assigned to receive PreProCare (n = 372) or usual care (n = 371). For the general satisfaction subscale, improvement at 24 months from baseline was significantly different between groups (P < .001). For the intervention group, mean scores at 24 months improved by 0.44 (SE, 0.06; P < .001) from baseline. This improvement was 0.5 standard deviation, which was clinically significant. The proportion reporting satisfaction with decision and no regret increased over time and was higher for the intervention group, compared with the usual care group at 24 months (P < .05). Among low-risk patients, a higher proportion of the intervention group was receiving active surveillance, compared with the usual care group (P < .001). CONCLUSION: Our patient-centered PreProCare intervention improved satisfaction with care, satisfaction with decision, reduced regrets, and aligned treatment choice with risk category. The majority of our participants had a high income, with implications for generalizability. Additional studies can evaluate the effectiveness of PreProCare as a mechanism for improving clinical and patient-reported outcomes in different settings.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Jayadevappa R, Chhatre S, Gallo JJ, et al. Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial. J Clin Oncol. 2019. PMID: 30860943. doi:10.1200/JCO.18.01091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。